1. Home
  2. FOFO vs ACET Comparison

FOFO vs ACET Comparison

Compare FOFO & ACET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

FOFO

Hang Feng Technology Innovation Co. Ltd. Ordinary Shares

N/A

Current Price

$5.74

Market Cap

85.2M

Sector

N/A

ML Signal

N/A

Logo Adicet Bio Inc.

ACET

Adicet Bio Inc.

HOLD

Current Price

$8.46

Market Cap

71.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FOFO
ACET
Founded
2017
1947
Country
Hong Kong
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
85.2M
71.3M
IPO Year
2025
N/A

Fundamental Metrics

Financial Performance
Metric
FOFO
ACET
Price
$5.74
$8.46
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$65.33
AVG Volume (30 Days)
64.6K
204.6K
Earning Date
03-13-2026
03-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.36
N/A
Revenue
$3,117,608.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$15.35
N/A
Revenue Growth
1597.65
N/A
52 Week Low
$4.53
$7.15
52 Week High
$68.00
$17.44

Technical Indicators

Market Signals
Indicator
FOFO
ACET
Relative Strength Index (RSI) 33.64 74.40
Support Level $5.56 $8.18
Resistance Level $6.14 $9.00
Average True Range (ATR) 0.50 0.47
MACD 0.09 -0.19
Stochastic Oscillator 16.82 58.46

Price Performance

Historical Comparison
FOFO
ACET

About FOFO Hang Feng Technology Innovation Co. Ltd. Ordinary Shares

Hang Feng Technology Innovation Co Ltd is committed to providing comprehensive corporate management consulting and asset management services, tailored to address the specific needs of each client. Its goal is to empower its clients to design, implement, and achieve their unique business and investment objectives. Its business consists of two main segments: (i) corporate management consulting services and (ii) asset management services. The corporate management consulting services include Management consulting, and Regulatory compliance and governance consulting.

About ACET Adicet Bio Inc.

Adicet Bio Inc is a clinical-stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. Its product candidate, ADI-001, a first-in-class allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, is being developed for the potential treatment of autoimmune diseases and relapsed or refractory aggressive B cell non-Hodgkin's lymphoma. Their pipeline also includes its preclinical candidate, ADI-270, an armored gamma delta CAR T cell product candidate targeting renal cell carcinoma, with potential for other CD70+ solid tumor and hematological malignancies indications.

Share on Social Networks: